Advertisement

Topics

ThromboGenics NV and BioInvent International Company Profile

06:17 EDT 21st September 2018 | BioPortfolio

ThromboGenics is a biotechnology company focused on the discovery and development of innovative biopharmaceuticals for the treatment of eye disease, vascular disease and cancer. The Company's lead product microplasmin is in Phase III clinical development for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent International; these include TB-402 (Anti-Factor VIII), a long acting anticoagulant, and TB-403 (anti-PlGF) for cancer.


News Articles [354 Associated News Articles listed on BioPortfolio]

ThromboGenics NV: ThromboGenics Enrolls First Patient in Phase 1 Clinical Study Evaluating THR-149, a plasma kallikrein inhibitor, for treatment of Diabetic Macular Edema (DME)

Press release Leuven, Belgium, 25 May 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, announces that it has successfu...

ThromboGenics NV: ThromboGenics to present a preclinical overview of its two most advanced diabetic eye disease clinical candidates, THR-317 and THR-149, at EASDec 2018

Press release Leuven, Belgium, 23 May 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, announces that its CSO Jean Fey...

BioInvent’s Deal with Roche – Are Early-Stage Deals on the Rise?

In this interview Fintan Walton speaks with Martin Wiles, Vice President of Business Development of BioInvent International based in Lund Sweden about the deal which Bio Invent has entered into with R...

ThromboGenics NV: ThromboGenics becomes "Oxurion"

Press release Shareholders approve new name which better reflects the Company's ambition to deliver best in class therapies for back of the eye disorders Leuven, Belgium, 3 September 2018 - Thromb...

ThromboGenics NV: ThromboGenics Business Update - H1 2018

Press release6 September 2018Regulated Information Positive Topline Results for Diabetic Eye Disease Portfolio Shareholder approval for company name change to Oxurion NV €10 million equity investm.....

ThromboGenics NV: ThromboGenics Business Update - FY 2017

Press release 15 March 2018Regulated Information Advancing Preclinical and Clinical Diabetic Eye Disease Portfolio Regained global rights to JETREA from Alcon, a Novartis company,and received €53......

F.I.R.S.T.™ - a platform for effective drug discovery

The strategic value of BioInvent consists of the patented technology platforms F I R S T™ and n-CoDeR®, as well as considerable expertise in pre-clinical and clinical development and the production...

ThromboGenics NV: Oxurion nv Enrolls First Patient in Phase 1 Clinical Trial Evaluating THR-687, a Novel Pan-RGD Integrin Antagonist, for Treatment of Diabetic Macular Edema (DME)

Leuven, Belgium, 20 September 2018 - Oxurion NV (Euronext Brussels: OXUR - formerly known as ThromboGenics), a biopharmaceutical company developing innovative treatments to preserve vision in pati...

Drugs and Medications [422 Associated Drugs and Medications listed on BioPortfolio]

Pvp iodine prep pad [Professional Disposables International, Inc.]

Drug Facts

Sani professional brand sani-hands for kids [Profesional Disposables International, Inc.]

SANI PROFESSIONAL BRAND SANI-HANDS FOR KIDS INSTANT HAND SANITIZING WIPES

Muscle and joint vanishing scent [LIFElabs, a Division of Atico International USA, INC.]

LIFElabs, a Division of Atico International USA, INC.

Sani-hands [Professional Disposables International, Inc.]

SANI PROFESSIONAL BRAND SANI-HANDS FOR KIDS INSTANT HAND SANITIZING WIPES

Pdi sani-hands for kids [Professional Disposables International, Inc.]

PDI SANI-HANDS FOR KIDS ANTIMICROBIAL ALCOHOL GEL HAND WIPES

PubMed Articles [479 Associated PubMed Articles listed on BioPortfolio]

18th International Congress on Infectious Diseases/XVIII Congreso SADI 2018 - It takes two to Tango.

Respiratory Management of Extremely Preterm Infants: An International Survey.

There are significant international variations in chronic lung disease rates among very preterm infants yet there is little data on international variations in respiratory strategies.

Cohort Profile: The International Mobility In Aging Study (IMIAS).

International assessment of inter- and intrarater reliability of the International Frontal Sinus Anatomy Classification system.

Inconsistencies in the nomenclature of structures of the frontal sinus have impeded the development of a validated "reference standard" classification system that surgeons can reliably agree upon. The...

International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Critical examination of the quality and validity of available allergic rhinitis (AR) literature is necessary to improve understanding and to appropriately translate this knowledge to clinical care of ...

Clinical Trials [1011 Associated Clinical Trials listed on BioPortfolio]

Epidogs International Inventory of Seizure Alert Dogs

This international research project looks at the reliability of canine seizure alerting behaviour in epilepsy patients. In the first stage an international database to identify the size an...

International AGD Database; Determinants of AGD and Establishment of Normative Data

Aim: To collate data on Anogenital Distance (AGD) from several population studies to build an international database for Anogenital Distance (AGD) Primary objective: To build a database p...

International Study on NoSocomial Pneumonia in Intensive CaRE

The International study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE) is a prospective, international, multicentre, observational, cohort study. The study aims to provide up-to...

Effectiveness Study of the International Child Development Program

The objective of this study is to evaluate the effect of the International Child Development Program (ICDP). Research questions to be answered: 1. Does the ICDP affect children's psycho...

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

LCH III is an international, multicentric, prospective clinical study comprised of: - a randomized clinical trial for multisystem "RISK" patients and - a randomized clinical trial ...

Companies [1287 Associated Companies listed on BioPortfolio]

ThromboGenics NV and BioInvent International

ThromboGenics is a biotechnology company focused on the discovery and development of innovative biopharmaceuticals for the treatment of eye disease, vascular disease and cancer. The Company's lead...

BioInvent International AB and ThromboGenics NV

BioInvent International AB, listed on the NASDAQ OMX Stockholm (BINV), is a research-based

BioInvent

BioInvent International AB, listed on the NASDAQ OMX Stockholm (BINV), is a research-based pharmaceutical company that focuses on developing antibody drugs. The Company's pipeline...

Bioinvent International AB

BioInvent International is a unique company dedicated to working with clients to ensure their success in the discovery, development and manufacture of antibody drugs. The discovery of new drug targets...

BioInvent International AB (publ)

BioInvent is dedicated to helping realize the innovator's innovation originating from any drug discovery labs in corporate or academic environments. Based on this commitment, we actively seek collabor...

More Information about "ThromboGenics NV and BioInvent International" on BioPortfolio

We have published hundreds of ThromboGenics NV and BioInvent International news stories on BioPortfolio along with dozens of ThromboGenics NV and BioInvent International Clinical Trials and PubMed Articles about ThromboGenics NV and BioInvent International for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ThromboGenics NV and BioInvent International Companies in our database. You can also find out about relevant ThromboGenics NV and BioInvent International Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record